Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Year: 2010
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: naltrexone, bupropion, Contrave, obesity, weight loss, combination pharmacotherapy, sustained-release formulation, dose escalation, body mass index, dyslipidemia, hypertension, hypocaloric diet, physical activity, weight loss maintenance, relapse prevention, adverse events, drug safety, antidepressant side effects, opioid antagonists
Open Access status: closed
Funder: Orexigen Therapeutics
OpenAlex ID: W2110438413
